Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Kim

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Clinical Colorectal Cancer|April 18, 2020
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World StudyEric François, Laurent Mineur, Gaël Deplanque, et al.
International Journal of Cancer|August 16, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancersLaurie Spehner, Adeline Bouard, Antoine El Kaddissi, et al.
Clinical Genitourinary Cancer|December 3, 2014
Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR StudyAntoine Thiery-Vuillemin, Christine Theodore, Lutz Jacobasch, et al.
Oncotarget|November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatmentSindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2015
Evaluation of a 36 Gy elective node irradiation dose in anal cancerAlexis Lépinoy, Nicolas Lescut, Marc Puyraveau, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Cancer Medicine|October 12, 2016
Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinomaFrédéric Fiteni, Sophie Paget-Bailly, Mathieu Messager, et al.
BMC Gastroenterology|August 14, 2014
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyFrédéric Fiteni, Marine Jary, Franck Monnien, et al.
Clinical Colorectal Cancer|October 23, 2012
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancerErion Dobi, Franck Monnien, Stefano Kim, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Clinical Colorectal Cancer|April 18, 2020
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World StudyEric François, Laurent Mineur, Gaël Deplanque, et al.
International Journal of Cancer|August 16, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancersLaurie Spehner, Adeline Bouard, Antoine El Kaddissi, et al.
Clinical Genitourinary Cancer|December 3, 2014
Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR StudyAntoine Thiery-Vuillemin, Christine Theodore, Lutz Jacobasch, et al.
Oncotarget|November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatmentSindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 17, 2015
Evaluation of a 36 Gy elective node irradiation dose in anal cancerAlexis Lépinoy, Nicolas Lescut, Marc Puyraveau, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Cancer Medicine|October 12, 2016
Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinomaFrédéric Fiteni, Sophie Paget-Bailly, Mathieu Messager, et al.
BMC Gastroenterology|August 14, 2014
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyFrédéric Fiteni, Marine Jary, Franck Monnien, et al.
Clinical Colorectal Cancer|October 23, 2012
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancerErion Dobi, Franck Monnien, Stefano Kim, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Pageof 7